Evidence map›Paper›PMID 32015578›Full record

ArticleBulletin of the World Health Organization2020

Tailored HIV programmes and universal health coverage.

Charles B Holmes, Miriam Rabkin, Nathan Ford, Peter Preko, Sydney Rosen, Tom Ellman, Peter Ehrenkranz

Open access · diamondAbstract read
In one paragraph

Article in Bulletin of the World Health Organization, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Universal health coverage: time to deliver on political promises.Bulletin of the World Health Organization · 2020
    Article
  14. HIV prevention and care as part of universal health coverage.Bulletin of the World Health Organization · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Charles B HolmesGeorgetown University School of Medicine, 3900 Reservoir Rd NW, Washington, DC 20007, United States of America (USA).
Miriam RabkinICAP at Columbia University, Mailman School of Public Health, New York, USA.
Nathan FordDepartment of HIV and Global Hepatitis Programme, World Health Organization, Geneva, Switzerland.
Peter PrekoICAP at Columbia University, Mailman School of Public Health, New York, USA.
Sydney RosenHealth Economics and Epidemiology Research Office, University of the Witwatersrand, Johannesburg, South Africa.
Tom EllmanMedical Department, Médecins Sans Frontières, Cape Town, South Africa.
Peter EhrenkranzTB and HIV, Bill & Melinda Gates Foundation, Seattle, USA.
ICAP Global HealthMédecins Sans Frontières · ZAUniversity of the Witwatersrand · ZAWorld Health Organization · CH

Funding

World Health Organization 001
6 · The paper itself

Abstract

Improvements in geospatial health data and tailored human immunodeficiency virus (HIV) testing, prevention and treatment have led to greater microtargeting of the HIV response, based on location, risk, clinical status and disease burden. These approaches show promise for achieving control of the HIV epidemic. At the same time, United Nations Member States have committed to achieving broader health and development goals by 2030, including universal health coverage (UHC). HIV epidemic control will facilitate UHC by averting the need to commit ever-increasing resources to HIV services. Yet an overly targeted HIV response could also distort health systems, impede integration and potentially threaten broader health goals. We discuss current approaches to achieving both UHC and HIV epidemic control, noting potential areas of friction between disease-specific microtargeting and integrated health systems, and highlighting opportunities for convergence that could enhance both initiatives. Examples of these programmatic elements that could be better aligned include: improved information systems with unique identifiers to track and monitor individuals across health services and the life course; strengthened subnational data use; more accountable supply chains that supply a broad range of services; and strengthened community-based services and workforces. We argue that the response both to HIV and to broader health threats should use these areas of convergence to increase health systems efficiency and mitigate the harm of any potential decrease in health funding. Further investments in implementation and monitoring of these programme elements will be needed to make progress towards both UHC and HIV epidemic control.

Indexed as

HIV InfectionsUniversal Health InsuranceCommunicable Disease ControlHealth PromotionHumansInsurance CoverageInternationality

Identifiers

PMID32015578
PMCPMC6986224
OpenAlexW3003493838

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.